-transparent.png){kind=logo}
The psychotomimetic effects of Phencyclidine (PCP) often have a delayed onset and extend far from the time plasma drug levels reach their peak. PCP at a low dose is considered selective for actions on the N-methyl-D-aspartate-PCP receptor. We evaluated effects of PCP (2 and 10 mg/kg, IP) on regional content of neuropeptide Y (NPY)-like immunoreactivity (LI) and peptide YY (PYY)-LI, in the rat brain. Thirty minutes after administration of PCP, NPY-LI levels were significantly elevated in some limbic structures following both doses. A significant, widespread increase in NPY-LI levels was induced 2 hours after administration of the higher dose of PCP. On the contrary, NPY-LI was significantly decreased in a number of the regions 24 hours after PCP. The extent of reduction was less following the higher dose of PCP than following the lower dose. PCP did not cause a consistent effect on PYY-LI. The findings suggest that effects of PCP on brain NPY content might depend on the dose and the interval between administration of the drug and sacrifice.
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
December 1990,
Cellular and molecular neurobiology,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
January 1991,
European journal of pharmacology,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
June 1988,
Regulatory peptides,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
December 1989,
European journal of pharmacology,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
December 1988,
Molecular pharmacology,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
December 2012,
Neuropeptides,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
August 1989,
The Journal of neuroscience : the official journal of the Society for Neuroscience,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
April 1996,
Regulatory peptides,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
August 2002,
Neuropeptides,
K Sakai, and
K Maeda, and
S Okuyama, and
C Tanaka
March 1988,
Acta physiologica Scandinavica,
